» Articles » PMID: 39995963

The Weight-adjusted-waist Index Predicts All-cause and Cardiovascular Mortality in Hypertension

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Weight-adjusted-waist (WWI) is a novel indicator of obesity that reflects the degree of central obesity in the human body.

Objectives: The study aimed to explore the relationship between WWI and mortality in hypertensive individuals.

Methods: Cross-sectional data from the 2001-2018 National Health and Nutrition Examination Survey (NHANES) dataset were used in this study. The relationship between WWI and mortality was assessed using a weighted Cox proportional risk model; the nonlinear relationship was explored using restricted cubic splines. The robustness of the results was verified by subgroup and sensitivity analyses.

Results: A cohort of 11,556 people with a diagnosis of hypertension was included in this study. As a continuous variable, WWI was linked to higher rates of mortality from all-cause (HR = 1.23, 95% CI = 1.14, 1.33) and cardiovascular disease (CVD) (HR = 1.43, 95% CI = 1.23, 1.66) with hypertension in Model 3 adjusted for variables. Using WWI as a tertile categorical variable, individuals in the highest tertile had a 33% higher risk of all-cause death (HR = 1.33, 95% CI = 1.14, 1.56) and a 65% higher risk of CVD death (HR = 1.65, 95% CI = 1.19, 2.27) than individuals in the lowest tertile. According to the subgroup analysis, almost all groups showed a consistent positive correlation between WWI and mortality related to all-cause and CVD.

Conclusion: In adults with hypertension, there is a positive association between WWI and all-cause and CVD mortality.

References
1.
Kim J, Choi J, Vella C, Criqui M, Allison M, Kim N . Associations between Weight-Adjusted Waist Index and Abdominal Fat and Muscle Mass: Multi-Ethnic Study of Atherosclerosis. Diabetes Metab J. 2022; 46(5):747-755. PMC: 9532169. DOI: 10.4093/dmj.2021.0294. View

2.
Nimptsch K, Konigorski S, Pischon T . Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism. 2018; 92:61-70. DOI: 10.1016/j.metabol.2018.12.006. View

3.
Grassi G, Seravalle G, DellOro R, TURRI C, Bolla G, Mancia G . Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000; 36(4):538-42. DOI: 10.1161/01.hyp.36.4.538. View

4.
Landsberg L, Aronne L, Beilin L, Burke V, Igel L, Lloyd-Jones D . Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich). 2013; 15(1):14-33. PMC: 8108268. DOI: 10.1111/jch.12049. View

5.
Sowers J . Diabetes mellitus and vascular disease. Hypertension. 2013; 61(5):943-7. PMC: 3648858. DOI: 10.1161/HYPERTENSIONAHA.111.00612. View